Analystreport

Erytech Pharma SA (NASDAQ: ERYP) had its "buy" rating re-affirmed by analysts at Cowen Inc.

Erytech Pharma S.A. - American Depositary Shares  (ERYP) 
US:NASDAQ Investor Relations: investors.erytech.com